All Stories

  1. Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway
  2. New 4-(arylidene)amino-1,2,4-traizole-5-thiol derivatives and their acyclo thioglycosides as α-glucosidase and α-amylase inhibitors: Design, synthesis, and molecular modelling studies
  3. The hepatotoxicity of Nigella sativa oil linked to the route of Administration
  4. Curcumin Zn oxide Nanoparticles
  5. Therapeutic Screening of Herbal Remedies for the Management of Diabetes
  6. Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes
  7. polyaromatic hydrocarbons
  8. Erectile dysfunction drugs altered the activities of antioxidant enzymes, oxidative stress and the protein expressions of some cytochrome P450 isozymes involved in the steroidogenesis of steroid hormones
  9. Cell Signaling in Hepatocellular Carcinoma
  10. Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers
  11. Action of Thioglycosides on the Oxidative Stress and Glycosidases.
  12. Professor of biochemistry. The duties include teaching and research activities.
  13. Antioxidants and radical scavenging role of Leek (Allium kurrat) against aflatoxin-contaminated peanut
  14. N-nitrosamines induced infertility and hepatotoxicity in male rabbits
  15. Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs
  16. Zinc and curcumin lower arylsulfatses and some metabolic parameters in streptozotocin-induced diabetes
  17. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease in lebanese patients with diabetic nephropathy
  18. Drug-Metabolizing Enzymes and Metabolic Diseases: Role of Antioxidants
  19. Nigella sativaRelieves the Altered Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats Fed with a High-Fat Diet
  20. Diabetes and Cell Signaling
  21. Protein Phosphorylation
  22. Effect of Natural Products on Some Glycosidases and Their Expected Hypoglycemic Potential
  23. Aspartate Transcarbamylase
  24. Biological Effect of Glycosyl-Oxadiazolinethione and Glycosyl-sulfanyloxadiazole Derivatives through their in vitro Inhibition of Glycosidases from Bacteria and Normal or Diabetic Rats
  25. Anti-diabetic activity of different oils through their effect on arylsulfatases
  26. Arylsufatases
  27. Inhibition of Glycosidases
  28. Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinoma
  29. Detection of New Point Mutations of BRCA1 and BRCA2 in Breast Cancer Patients
  30. Importance of Growth Factors
  31. Some heterocyclic thione derivatives exhibit anticoccidial activity by inhibiting glycosidases.
  32. Enzyme Inhibitors as Therapeutic Tools
  33. Effect of calcium treatment on blood parameters, gonadal development and the structure of bone in immature female rats
  34. CYP1A1, CYP2E1, and GSTM1 Gene Polymorphisms and Susceptibility to Colorectal and Gastric Cancer Among Lebanese
  35. Inhibition of α-glucosidase and α-amylase by diaryl derivatives of imidazole-thione and 1,2,4-triazole-thiol
  36. The clinical relevance of urine-based markers for diagnosis of bladder cancer
  37. Succinate cytochrome c reductase in schistosomiasis: in vitro inhibition by some schistosomicidal drugs
  38. Inhibition of mammalian aspartate transcarbamylase by quinazolinone derivatives
  39. In vitroeffect of schistosomicidal drugs on hepatic arylsulfatase B from theSchistosoma-infected mouse
  40. Effect of some Cardiac and Respiratory Drugs on Succinate-Cytochrome c Reductase
  41. Some hydrolases in human schistosomiasis with special reference to arylsulfatase B
  42. INHIBITION OF SOME HEPATIC GLYCOSIDASES BY THE DISECO NUCLEOSIDE, 4-AMINO-3-(D-GLUCOPENTITOL-1-YL)- 5-MERCAPTO-1,2,4-TRIAZOLE AND ITS 3-METHYL ANALOG
  43. Inhibition of Succinate-cytochrome C Reductase by a Ferromacrocyclic Complex
  44. Inhibition of some hepatic lysosomal glycosidases by ethanolamines and phenyl 6-deoxy-6-(morpholin-4-yl)-β-d-glucopyranoside
  45. Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells
  46. Mechanism of pepsin-catalyzed aminotranspeptidation reactions
  47. Secondary Substrate Binding in Aspartic Proteinases: Contributions of Subsites S3 and S′2 to kcat
  48. Alterations of protein kinase isozymes in transplantable human lung cancer with special reference to the phosphorylation of arylsulfatase B
  49. Alterations of protein kinase isozymes in transplantable human lung cancer with special reference to the phosphorylation of arylsulfatase B
  50. Phosphorylation of human lysosomal arylsulfatase B by cAMP-dependent protein kinase. Different sites of phosphorylation between normal and cancer tissues.
  51. The Use of Liposomes in Enzymes and Drug Design